Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of the American College of Cardiology|November 6, 2025
Transcatheter Mitral Valve Replacement for Severe Mitral Annular Calcification: Primary Outcomes from the SUMMIT-MAC StudyPaul Sorajja, Vinod H Thourani, Jason H Rogers, et al.
JACC. Cardiovascular Interventions|May 12, 2026
30-Day Outcomes of a Single-Stage Transfemoral Mitral Valve Replacement System in Severe Mitral Valve DiseasePradeep K Yadav, Torsten P Vahl, Vinod H Thourani, et al.
The American Journal of Cardiology|June 13, 2024
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney DiseaseNader Mankerious, Ralph Toelg, Birgit Vogel, et al.
JACC. Cardiovascular Interventions|February 19, 2025
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCIVijay Kunadian, Mauro Gitto, Birgit Vogel, et al.
JACC. Cardiovascular Interventions|September 10, 2021
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent ImplantationRoxana Mehran, Davide Cao, Dominick J Angiolillo, et al.
JACC. Cardiovascular Imaging|August 8, 2025
Echocardiographic Imaging Considerations for Post-Implant Evaluation of the Transcatheter EVOQUE Tricuspid Valve Replacement SystemAnna Sannino, Federica Ilardi, Rebecca T Hahn, et al.
JACC. Cardiovascular Interventions|June 26, 2026
Real-World Outcomes of Dedicated Leaflet Modification for Bioprosthetic Valve-In-Valve TAVR: A 150-Patient Commercial ExperienceRaj R Makkar, Aakriti Gupta, Ignacio Inglessis, et al.
JACC. Advances|September 27, 2025
Multicenter Prospective Assessment of Coronary Microvascular Dysfunction: Primary Results of the FlowLab StudyBrian A Bergmark, Samit Shah, Olga Toleva, et al.
Journal of the American College of Cardiology|November 19, 2021
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCIMarco Valgimigli, Davide Cao, Dominick J Angiolillo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2024
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesDavide Cao, Pascal Vranckx, Marco Valgimigli, et al.
Pageof 4